ストックスクリーナーアプリを入手
73.57
0.93%
-0.69
アフターアワーズ：
73.57
前日終値:
$74.26
開ける：
$74.05
24時間の取引高:
1.16M
Relative Volume:
1.73
時価総額：
$3.70B
収益：
$379.25M
当期純損益:
$-77.34M
株価収益率:
-45.63
EPS:
-1.6122
ネットキャッシュフロー:
$-27.87M
1週間 パフォーマンス:
-2.32%
1か月 パフォーマンス:
+2.45%
6か月 パフォーマンス:
+56.33%
1年 パフォーマンス:
+88.69%
1日の値動き範囲:
$73.09
$74.54
1週間の範囲:
$72.90
$75.56
52週間の値動き範囲:
$36.88
$78.09
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
名前
Mirum Pharmaceuticals Inc
セクター
電話
650-667-4085
住所
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
MIRM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
73.57 | 3.73B | 379.25M | -77.34M | -27.87M | -1.6122 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-11 | 再開されました | Stifel | Buy |
| 2025-05-19 | 再開されました | H.C. Wainwright | Buy |
| 2024-04-17 | 開始されました | Stifel | Buy |
| 2023-12-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2023-11-20 | 再開されました | JP Morgan | Overweight |
| 2023-11-13 | 開始されました | Morgan Stanley | Overweight |
| 2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-10-17 | 再開されました | Evercore ISI | Outperform |
| 2023-09-20 | 開始されました | JMP Securities | Mkt Outperform |
| 2022-09-01 | 開始されました | Citigroup | Buy |
| 2021-09-20 | 開始されました | JP Morgan | Overweight |
| 2020-08-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | 開始されました | H.C. Wainwright | Buy |
| 2020-07-31 | 開始されました | Piper Sandler | Overweight |
| 2020-06-25 | 開始されました | Robert W. Baird | Outperform |
| 2019-08-12 | 開始されました | Citigroup | Buy |
| 2019-08-12 | 開始されました | Evercore ISI | Outperform |
| 2019-08-12 | 開始されました | Guggenheim | Buy |
| 2019-08-12 | 開始されました | ROTH Capital | Buy |
| 2019-08-12 | 開始されました | Raymond James | Outperform |
すべてを表示
Mirum Pharmaceuticals Inc (MIRM) 最新ニュース
Mirum stock is a new Buy at TD Cowen (MIRM:NASDAQ) - Seeking Alpha
TD Cowen initiates coverage on Mirum Pharmaceuticals stock with Buy rating - Investing.com
CRMD vs. MIRM: Which Specialized Biotech Stock is the Better Pick? - sharewise.com
Contravisory Investment Management Inc. Acquires Shares of 5,307 Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Loss-Making Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Expected To Breakeven In The Medium-Term - Yahoo
Atle Fund Management AB Grows Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
12,200 Shares in Mirum Pharmaceuticals, Inc. $MIRM Bought by Strs Ohio - MarketBeat
Gainers Report: What are Mirum Pharmaceuticals Inc.’s earnings expectationsJuly 2025 Trade Ideas & Safe Entry Momentum Stock Tips - خودرو بانک
Earnings Recap: Should I hold or sell Mirum Pharmaceuticals Inc nowPortfolio Update Summary & Fast Momentum Stock Entry Tips - khodrobank.com
Bond Watch: What is Mirum Pharmaceuticals Inc. s debt to equity ratioMarket Growth Summary & Pattern Based Trade Signal System - khodrobank.com
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $74.44 Consensus Target Price from Brokerages - MarketBeat
Investment Recap: Is Mirum Pharmaceuticals Inc impacted by rising ratesProduct Launch & Technical Pattern Alert System - خودرو بانک
Retail Trends: Is Springview Holdings Ltd showing insider buyingTrade Entry Report & Expert-Curated Trade Recommendations - خودرو بانک
Mirum Pharmaceuticals, Inc. $MIRM Shares Sold by Millennium Management LLC - MarketBeat
Risk Report: Will Mirum Pharmaceuticals Inc benefit from AI trends2025 Market Overview & Precise Swing Trade Alerts - خودرو بانک
Citizens JMP Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $81 - 富途牛牛
H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $80 - 富途牛牛
Citizens JMP reiterates Market Outperform rating on Mirum Pharmaceuticals stock - Investing.com Canada
Mirum Pharmaceuticals, Inc. $MIRM Shares Bought by Rhumbline Advisers - Defense World
JPMorgan Chase & Co. Issues Positive Forecast for Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Price - MarketBeat
Activity Recap: Is Mirum Pharmaceuticals Inc impacted by rising ratesJuly 2025 Closing Moves & Consistent Return Investment Signals - خودرو بانک
Trade Report: Can Mirum Pharmaceuticals Inc. deliver consistent dividendsMarket Volume Summary & Free Community Consensus Stock Picks - خودرو بانک
Mirum Pharmaceuticals, Inc. $MIRM Holdings Increased by Woodline Partners LP - MarketBeat
Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 1-Year HighTime to Buy? - MarketBeat
Mirum Pharmaceuticals Announces Enrollment Completion in the Phase 2b VISTAS Study - Investing News Network
Mirum Pharma director Brege sells $1.26m in shares - Investing.com India
Mirum Pharma director Brege sells $1.26m in shares By Investing.com - Investing.com Canada
J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $77 - 富途牛牛
Adage Capital Partners GP L.L.C. Purchases 195,000 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Saira Ramasastry, Mirum director, sells $1.3m in shares By Investing.com - Investing.com Canada
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Mirum Pharmaceuticals (NASDAQ:MIRM) Sets New 52-Week HighHere's Why - MarketBeat
Eventide Asset Management LLC Sells 79,938 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum Pharmaceuticals at Morgan Stanley Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Mirum Pharmaceuticals announces enrollment completion in the phase 2b Vistas study - MarketScreener
Published on: 2025-09-08 12:42:47 - beatles.ru
Northern Trust Corp Decreases Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Multi factor analysis applied to Mirum Pharmaceuticals Inc.Weekly Investment Report & Stock Portfolio Risk Management - Newser
Is Mirum Pharmaceuticals Inc. stock overvalued or fairly priced2025 Geopolitical Influence & Short-Term High Return Ideas - خودرو بانک
PDT Partners LLC Has $6.19 Million Stock Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Is Mirum Pharmaceuticals Inc. forming bullish engulfing patternsEarnings Trend Report & Safe Entry Trade Signal Reports - خودرو بانک
Can Mirum Pharmaceuticals Inc. reach resistance levels soon2025 EndofYear Setup & Fast Gain Swing Alerts - خودرو بانک
Real time scanner hits for Mirum Pharmaceuticals Inc. explainedBond Market & AI Driven Stock Movement Reports - Newser
Sentiment analysis tools applied to Mirum Pharmaceuticals Inc.2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser
Is Mirum Pharmaceuticals Inc. forming a reversal patternPortfolio Growth Summary & Weekly Top Gainers Trade List - Newser
Published on: 2025-09-05 14:03:50 - Newser
Signal strength of Mirum Pharmaceuticals Inc. stock in tech scannersQuarterly Risk Review & Safe Capital Growth Stock Tips - Newser
Chart overlay techniques for tracking Mirum Pharmaceuticals Inc.Earnings Performance Report & Capital Efficiency Focused Ideas - Newser
Rafferty Asset Management LLC Raises Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Will Mirum Pharmaceuticals Inc. stock recover after recent dropMarket Movement Recap & Detailed Earnings Play Alerts - Newser
Mirum Pharmaceuticals Inc (MIRM) 財務データ
収益
当期純利益
現金流量
EPS
2.43%
大文字化:
|
ボリューム (24 時間):